Salvage Therapies After Failed Primary Radiation
We have learned that prostate cancer cells are amazingly adaptable. In fact, they can quickly become resistant to external radiation, making it less effective. That fact underscores our choice of combined radiation therapy whenever possible. We have found that by delivering half the “tumor-cidal” (killing) dose of radiation through an external delivery process and implanting the other half through brachytherapy intensifies the response, giving higher cure rates with lower side effects. Cancers don’t like change! In fact, cross specialty studies looking at breast cancer, colorectal cancer, head and neck cancers, etc. all demonstrate an increasing survival rate when a combination of therapies are used.
Patients experiencing recurrence following single modality radiation are often eligible for additional treatment using a different form of radiation. For instance, the man who had External Beam Radiation Therapy (EBRT) alone may find benefit from a small dose of DART (Dynamic Adaptive Radiotherapy) followed immediately by seed implantation (depending on the location of the active cancer cells).
Men who had brachytherapy alone as primary treatment might benefit from additional seeds of a different isotope. If the patient had Iodine-125 seeds, he might now have Palladium-103 seeds (referred to as a “crossover isotope”), or vice versa, along with DART to the surrounding periprostatic tissue and relevant lymph nodes. Again, the important determining factor is pinpointing the location of the active cancer cells.
Men with positive lymph nodes may be treated with radiation to the lymph nodes alone using the targeting sophistication of DART. Often these post-radiation recurrent patients will be prescribed hormonal therapy in addition to the new radiation.
It is possible for these men to have surgery following failed radiation, but in our opinion that would most likely be useless since the spread of cancer is typically not only in the gland but also outside it, so that removing the gland would not solve the problem.
Continue to Recurrence after Novel Treatments »
Continue to Recurrence after Surgery »
Patients experiencing recurrence following single modality radiation are often eligible for additional treatment using a different form of radiation. For instance, the man who had External Beam Radiation Therapy (EBRT) alone may find benefit from a small dose of DART (Dynamic Adaptive Radiotherapy) followed immediately by seed implantation (depending on the location of the active cancer cells).
Men who had brachytherapy alone as primary treatment might benefit from additional seeds of a different isotope. If the patient had Iodine-125 seeds, he might now have Palladium-103 seeds (referred to as a “crossover isotope”), or vice versa, along with DART to the surrounding periprostatic tissue and relevant lymph nodes. Again, the important determining factor is pinpointing the location of the active cancer cells.
Men with positive lymph nodes may be treated with radiation to the lymph nodes alone using the targeting sophistication of DART. Often these post-radiation recurrent patients will be prescribed hormonal therapy in addition to the new radiation.
It is possible for these men to have surgery following failed radiation, but in our opinion that would most likely be useless since the spread of cancer is typically not only in the gland but also outside it, so that removing the gland would not solve the problem.
Continue to Recurrence after Novel Treatments »
Continue to Recurrence after Surgery »